Optogenetics Actuators And Sensors Comprehensive Study by Type (Actuators (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin), Sensors (Genetically Encoded Calcium Indicators, Voltage-Sensitive Fluorescent Proteins, and pH Sensors)), Application (Neuroscience, Retinal Diseases Treatment, Hearing Problem Treatment, Behavioral Tracking, Cardiovascular Alignment, Pacing), Disease (Retinal Disorders, Parkinson’s Disease, Anxiety & Depression, Autism, Schizophrenia, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) Players and Region - Global Market Outlook to 2027

Optogenetics Actuators And Sensors Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 1.2%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Optogenetics actuators and sensors merge optics and genetics in a novel way. It enables one to use light to calculate or control the characteristics of known neurons or cells in a tissue with millisecond precision, even in a moving animal. Optogenetics actuators and sensors are a useful method for deciphering the underlying actions of neuronal mechanisms and reading various physiological phenomena. According to AMA Research, the market for Optogenetics Actuators And Sensors is expected to register a CAGR of 1.2% during the forecast period to 2027. This growth is primarily driven by Rise in incidence of neurological and mental disorders such as Parkinson’s disease, depression, and schizophrenia is driving the neurological disorders.

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Volume UnitN
Value UnitUSD (Million)
Key Companies in StudyAddgene (United States), Bruker (United States), Circuit Therapeutics (United States), Danaher (United States), Elliot Scientific (United States), Gensight Biologics (France), Merck KGaA (Germany), Prizmatix (Israel), The Jackson Laboratory (United States) and Thorlabs (United States)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Supplies sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Addgene (United States), Bruker (United States), Circuit Therapeutics (United States), Danaher (United States), Elliot Scientific (United States), Gensight Biologics (France), Merck KGaA (Germany), Prizmatix (Israel), The Jackson Laboratory (United States) and Thorlabs (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.

Market Drivers
  • Rise in incidence of neurological and mental disorders such as Parkinson’s disease, depression, and schizophrenia is driving the neurological disorders

Market Trend
  • Increasing use of optogenetics actuators and sensors to enhance understanding of neural circuit dysfunction

Restraints
  • High cost associated with the technique is expected to obstruct the optogenetics actuators and sensors market growth

Opportunities
Governments provide funds to research institutions as well as individual researchers for introducing novel technologies in neuroscience and ophthalmology

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Optogenetics Actuators And Sensors Study Sheds Light on
— The Optogenetics Actuators And Sensors Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Optogenetics Actuators And Sensors industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Optogenetics Actuators And Sensors industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Actuators (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin)
  • Sensors (Genetically Encoded Calcium Indicators, Voltage-Sensitive Fluorescent Proteins, and pH Sensors)
By Application
  • Neuroscience
  • Retinal Diseases Treatment
  • Hearing Problem Treatment
  • Behavioral Tracking
  • Cardiovascular Alignment
  • Pacing
By Disease
  • Retinal Disorders
  • Parkinson’s Disease
  • Anxiety & Depression
  • Autism
  • Schizophrenia
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in incidence of neurological and mental disorders such as Parkinson’s disease, depression, and schizophrenia is driving the neurological disorders
    • 3.3. Market Trends
      • 3.3.1. Increasing use of optogenetics actuators and sensors to enhance understanding of neural circuit dysfunction
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Optogenetics Actuators And Sensors, by Type, Application, Disease, Distribution Channel and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Optogenetics Actuators And Sensors (Value)
      • 5.2.1. Global Optogenetics Actuators And Sensors by: Type (Value)
        • 5.2.1.1. Actuators (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin)
        • 5.2.1.2. Sensors (Genetically Encoded Calcium Indicators, Voltage-Sensitive Fluorescent Proteins, and pH Sensors)
      • 5.2.2. Global Optogenetics Actuators And Sensors by: Application (Value)
        • 5.2.2.1. Neuroscience
        • 5.2.2.2. Retinal Diseases Treatment
        • 5.2.2.3. Hearing Problem Treatment
        • 5.2.2.4. Behavioral Tracking
        • 5.2.2.5. Cardiovascular Alignment
        • 5.2.2.6. Pacing
      • 5.2.3. Global Optogenetics Actuators And Sensors by: Disease (Value)
        • 5.2.3.1. Retinal Disorders
        • 5.2.3.2. Parkinson’s Disease
        • 5.2.3.3. Anxiety & Depression
        • 5.2.3.4. Autism
        • 5.2.3.5. Schizophrenia
        • 5.2.3.6. Others
      • 5.2.4. Global Optogenetics Actuators And Sensors by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacies
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Others
      • 5.2.5. Global Optogenetics Actuators And Sensors Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Optogenetics Actuators And Sensors: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Addgene (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bruker (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Circuit Therapeutics (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Danaher (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Elliot Scientific (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Gensight Biologics (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck KGaA (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Prizmatix (Israel)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. The Jackson Laboratory (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thorlabs (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Optogenetics Actuators And Sensors Sale, by Type, Application, Disease, Distribution Channel and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Optogenetics Actuators And Sensors (Value)
      • 7.2.1. Global Optogenetics Actuators And Sensors by: Type (Value)
        • 7.2.1.1. Actuators (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin)
        • 7.2.1.2. Sensors (Genetically Encoded Calcium Indicators, Voltage-Sensitive Fluorescent Proteins, and pH Sensors)
      • 7.2.2. Global Optogenetics Actuators And Sensors by: Application (Value)
        • 7.2.2.1. Neuroscience
        • 7.2.2.2. Retinal Diseases Treatment
        • 7.2.2.3. Hearing Problem Treatment
        • 7.2.2.4. Behavioral Tracking
        • 7.2.2.5. Cardiovascular Alignment
        • 7.2.2.6. Pacing
      • 7.2.3. Global Optogenetics Actuators And Sensors by: Disease (Value)
        • 7.2.3.1. Retinal Disorders
        • 7.2.3.2. Parkinson’s Disease
        • 7.2.3.3. Anxiety & Depression
        • 7.2.3.4. Autism
        • 7.2.3.5. Schizophrenia
        • 7.2.3.6. Others
      • 7.2.4. Global Optogenetics Actuators And Sensors by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacies
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Others
      • 7.2.5. Global Optogenetics Actuators And Sensors Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Optogenetics Actuators And Sensors: by Type(USD Million)
  • Table 2. Optogenetics Actuators And Sensors Actuators (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin) , by Region USD Million (2016-2021)
  • Table 3. Optogenetics Actuators And Sensors Sensors (Genetically Encoded Calcium Indicators, Voltage-Sensitive Fluorescent Proteins, and pH Sensors) , by Region USD Million (2016-2021)
  • Table 4. Optogenetics Actuators And Sensors: by Application(USD Million)
  • Table 5. Optogenetics Actuators And Sensors Neuroscience , by Region USD Million (2016-2021)
  • Table 6. Optogenetics Actuators And Sensors Retinal Diseases Treatment , by Region USD Million (2016-2021)
  • Table 7. Optogenetics Actuators And Sensors Hearing Problem Treatment , by Region USD Million (2016-2021)
  • Table 8. Optogenetics Actuators And Sensors Behavioral Tracking , by Region USD Million (2016-2021)
  • Table 9. Optogenetics Actuators And Sensors Cardiovascular Alignment , by Region USD Million (2016-2021)
  • Table 10. Optogenetics Actuators And Sensors Pacing , by Region USD Million (2016-2021)
  • Table 11. Optogenetics Actuators And Sensors: by Disease(USD Million)
  • Table 12. Optogenetics Actuators And Sensors Retinal Disorders , by Region USD Million (2016-2021)
  • Table 13. Optogenetics Actuators And Sensors Parkinson’s Disease , by Region USD Million (2016-2021)
  • Table 14. Optogenetics Actuators And Sensors Anxiety & Depression , by Region USD Million (2016-2021)
  • Table 15. Optogenetics Actuators And Sensors Autism , by Region USD Million (2016-2021)
  • Table 16. Optogenetics Actuators And Sensors Schizophrenia , by Region USD Million (2016-2021)
  • Table 17. Optogenetics Actuators And Sensors Others , by Region USD Million (2016-2021)
  • Table 18. Optogenetics Actuators And Sensors: by Distribution Channel(USD Million)
  • Table 19. Optogenetics Actuators And Sensors Hospital Pharmacies , by Region USD Million (2016-2021)
  • Table 20. Optogenetics Actuators And Sensors Retail Pharmacies , by Region USD Million (2016-2021)
  • Table 21. Optogenetics Actuators And Sensors Others , by Region USD Million (2016-2021)
  • Table 22. South America Optogenetics Actuators And Sensors, by Country USD Million (2016-2021)
  • Table 23. South America Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 24. South America Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 25. South America Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 26. South America Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 27. Brazil Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 28. Brazil Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 29. Brazil Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 30. Brazil Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 31. Argentina Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 32. Argentina Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 33. Argentina Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 34. Argentina Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 35. Rest of South America Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 36. Rest of South America Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 37. Rest of South America Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 38. Rest of South America Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 39. Asia Pacific Optogenetics Actuators And Sensors, by Country USD Million (2016-2021)
  • Table 40. Asia Pacific Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 41. Asia Pacific Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 42. Asia Pacific Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 43. Asia Pacific Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 44. China Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 45. China Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 46. China Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 47. China Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 48. Japan Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 49. Japan Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 50. Japan Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 51. Japan Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 52. India Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 53. India Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 54. India Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 55. India Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 56. South Korea Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 57. South Korea Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 58. South Korea Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 59. South Korea Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 60. Taiwan Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 61. Taiwan Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 62. Taiwan Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 63. Taiwan Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 64. Australia Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 65. Australia Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 66. Australia Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 67. Australia Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 68. Rest of Asia-Pacific Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 69. Rest of Asia-Pacific Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 71. Rest of Asia-Pacific Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 72. Europe Optogenetics Actuators And Sensors, by Country USD Million (2016-2021)
  • Table 73. Europe Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 74. Europe Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 75. Europe Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 76. Europe Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 77. Germany Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 78. Germany Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 79. Germany Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 80. Germany Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 81. France Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 82. France Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 83. France Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 84. France Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 85. Italy Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 86. Italy Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 87. Italy Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 88. Italy Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 89. United Kingdom Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 90. United Kingdom Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 91. United Kingdom Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 92. United Kingdom Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 93. Netherlands Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 94. Netherlands Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 95. Netherlands Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 96. Netherlands Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 97. Rest of Europe Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 98. Rest of Europe Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 99. Rest of Europe Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 100. Rest of Europe Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 101. MEA Optogenetics Actuators And Sensors, by Country USD Million (2016-2021)
  • Table 102. MEA Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 103. MEA Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 104. MEA Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 105. MEA Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 106. Middle East Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 107. Middle East Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 108. Middle East Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 109. Middle East Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 110. Africa Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 111. Africa Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 112. Africa Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 113. Africa Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 114. North America Optogenetics Actuators And Sensors, by Country USD Million (2016-2021)
  • Table 115. North America Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 116. North America Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 117. North America Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 118. North America Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 119. United States Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 120. United States Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 121. United States Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 122. United States Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 123. Canada Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 124. Canada Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 125. Canada Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 126. Canada Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 127. Mexico Optogenetics Actuators And Sensors, by Type USD Million (2016-2021)
  • Table 128. Mexico Optogenetics Actuators And Sensors, by Application USD Million (2016-2021)
  • Table 129. Mexico Optogenetics Actuators And Sensors, by Disease USD Million (2016-2021)
  • Table 130. Mexico Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2016-2021)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Optogenetics Actuators And Sensors: by Type(USD Million)
  • Table 142. Optogenetics Actuators And Sensors Actuators (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin) , by Region USD Million (2022-2027)
  • Table 143. Optogenetics Actuators And Sensors Sensors (Genetically Encoded Calcium Indicators, Voltage-Sensitive Fluorescent Proteins, and pH Sensors) , by Region USD Million (2022-2027)
  • Table 144. Optogenetics Actuators And Sensors: by Application(USD Million)
  • Table 145. Optogenetics Actuators And Sensors Neuroscience , by Region USD Million (2022-2027)
  • Table 146. Optogenetics Actuators And Sensors Retinal Diseases Treatment , by Region USD Million (2022-2027)
  • Table 147. Optogenetics Actuators And Sensors Hearing Problem Treatment , by Region USD Million (2022-2027)
  • Table 148. Optogenetics Actuators And Sensors Behavioral Tracking , by Region USD Million (2022-2027)
  • Table 149. Optogenetics Actuators And Sensors Cardiovascular Alignment , by Region USD Million (2022-2027)
  • Table 150. Optogenetics Actuators And Sensors Pacing , by Region USD Million (2022-2027)
  • Table 151. Optogenetics Actuators And Sensors: by Disease(USD Million)
  • Table 152. Optogenetics Actuators And Sensors Retinal Disorders , by Region USD Million (2022-2027)
  • Table 153. Optogenetics Actuators And Sensors Parkinson’s Disease , by Region USD Million (2022-2027)
  • Table 154. Optogenetics Actuators And Sensors Anxiety & Depression , by Region USD Million (2022-2027)
  • Table 155. Optogenetics Actuators And Sensors Autism , by Region USD Million (2022-2027)
  • Table 156. Optogenetics Actuators And Sensors Schizophrenia , by Region USD Million (2022-2027)
  • Table 157. Optogenetics Actuators And Sensors Others , by Region USD Million (2022-2027)
  • Table 158. Optogenetics Actuators And Sensors: by Distribution Channel(USD Million)
  • Table 159. Optogenetics Actuators And Sensors Hospital Pharmacies , by Region USD Million (2022-2027)
  • Table 160. Optogenetics Actuators And Sensors Retail Pharmacies , by Region USD Million (2022-2027)
  • Table 161. Optogenetics Actuators And Sensors Others , by Region USD Million (2022-2027)
  • Table 162. South America Optogenetics Actuators And Sensors, by Country USD Million (2022-2027)
  • Table 163. South America Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 164. South America Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 165. South America Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 166. South America Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 167. Brazil Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 168. Brazil Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 169. Brazil Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 170. Brazil Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 171. Argentina Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 172. Argentina Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 173. Argentina Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 174. Argentina Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 175. Rest of South America Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 176. Rest of South America Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 177. Rest of South America Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 178. Rest of South America Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 179. Asia Pacific Optogenetics Actuators And Sensors, by Country USD Million (2022-2027)
  • Table 180. Asia Pacific Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 181. Asia Pacific Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 182. Asia Pacific Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 183. Asia Pacific Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 184. China Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 185. China Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 186. China Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 187. China Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 188. Japan Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 189. Japan Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 190. Japan Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 191. Japan Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 192. India Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 193. India Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 194. India Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 195. India Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 196. South Korea Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 197. South Korea Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 198. South Korea Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 199. South Korea Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 200. Taiwan Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 201. Taiwan Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 202. Taiwan Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 203. Taiwan Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 204. Australia Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 205. Australia Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 206. Australia Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 207. Australia Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 208. Rest of Asia-Pacific Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 209. Rest of Asia-Pacific Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 210. Rest of Asia-Pacific Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 211. Rest of Asia-Pacific Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 212. Europe Optogenetics Actuators And Sensors, by Country USD Million (2022-2027)
  • Table 213. Europe Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 214. Europe Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 215. Europe Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 216. Europe Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 217. Germany Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 218. Germany Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 219. Germany Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 220. Germany Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 221. France Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 222. France Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 223. France Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 224. France Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 225. Italy Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 226. Italy Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 227. Italy Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 228. Italy Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 229. United Kingdom Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 230. United Kingdom Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 231. United Kingdom Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 232. United Kingdom Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 233. Netherlands Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 234. Netherlands Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 235. Netherlands Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 236. Netherlands Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 237. Rest of Europe Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 238. Rest of Europe Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 239. Rest of Europe Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 240. Rest of Europe Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 241. MEA Optogenetics Actuators And Sensors, by Country USD Million (2022-2027)
  • Table 242. MEA Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 243. MEA Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 244. MEA Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 245. MEA Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 246. Middle East Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 247. Middle East Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 248. Middle East Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 249. Middle East Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 250. Africa Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 251. Africa Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 252. Africa Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 253. Africa Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 254. North America Optogenetics Actuators And Sensors, by Country USD Million (2022-2027)
  • Table 255. North America Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 256. North America Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 257. North America Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 258. North America Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 259. United States Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 260. United States Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 261. United States Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 262. United States Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 263. Canada Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 264. Canada Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 265. Canada Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 266. Canada Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 267. Mexico Optogenetics Actuators And Sensors, by Type USD Million (2022-2027)
  • Table 268. Mexico Optogenetics Actuators And Sensors, by Application USD Million (2022-2027)
  • Table 269. Mexico Optogenetics Actuators And Sensors, by Disease USD Million (2022-2027)
  • Table 270. Mexico Optogenetics Actuators And Sensors, by Distribution Channel USD Million (2022-2027)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Optogenetics Actuators And Sensors: by Type USD Million (2016-2021)
  • Figure 5. Global Optogenetics Actuators And Sensors: by Application USD Million (2016-2021)
  • Figure 6. Global Optogenetics Actuators And Sensors: by Disease USD Million (2016-2021)
  • Figure 7. Global Optogenetics Actuators And Sensors: by Distribution Channel USD Million (2016-2021)
  • Figure 8. South America Optogenetics Actuators And Sensors Share (%), by Country
  • Figure 9. Asia Pacific Optogenetics Actuators And Sensors Share (%), by Country
  • Figure 10. Europe Optogenetics Actuators And Sensors Share (%), by Country
  • Figure 11. MEA Optogenetics Actuators And Sensors Share (%), by Country
  • Figure 12. North America Optogenetics Actuators And Sensors Share (%), by Country
  • Figure 13. Global Optogenetics Actuators And Sensors share by Players 2021 (%)
  • Figure 14. Global Optogenetics Actuators And Sensors share by Players (Top 3) 2021(%)
  • Figure 15. Global Optogenetics Actuators And Sensors share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Addgene (United States) Revenue, Net Income and Gross profit
  • Figure 18. Addgene (United States) Revenue: by Geography 2021
  • Figure 19. Bruker (United States) Revenue, Net Income and Gross profit
  • Figure 20. Bruker (United States) Revenue: by Geography 2021
  • Figure 21. Circuit Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 22. Circuit Therapeutics (United States) Revenue: by Geography 2021
  • Figure 23. Danaher (United States) Revenue, Net Income and Gross profit
  • Figure 24. Danaher (United States) Revenue: by Geography 2021
  • Figure 25. Elliot Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 26. Elliot Scientific (United States) Revenue: by Geography 2021
  • Figure 27. Gensight Biologics (France) Revenue, Net Income and Gross profit
  • Figure 28. Gensight Biologics (France) Revenue: by Geography 2021
  • Figure 29. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Merck KGaA (Germany) Revenue: by Geography 2021
  • Figure 31. Prizmatix (Israel) Revenue, Net Income and Gross profit
  • Figure 32. Prizmatix (Israel) Revenue: by Geography 2021
  • Figure 33. The Jackson Laboratory (United States) Revenue, Net Income and Gross profit
  • Figure 34. The Jackson Laboratory (United States) Revenue: by Geography 2021
  • Figure 35. Thorlabs (United States) Revenue, Net Income and Gross profit
  • Figure 36. Thorlabs (United States) Revenue: by Geography 2021
  • Figure 37. Global Optogenetics Actuators And Sensors: by Type USD Million (2022-2027)
  • Figure 38. Global Optogenetics Actuators And Sensors: by Application USD Million (2022-2027)
  • Figure 39. Global Optogenetics Actuators And Sensors: by Disease USD Million (2022-2027)
  • Figure 40. Global Optogenetics Actuators And Sensors: by Distribution Channel USD Million (2022-2027)
  • Figure 41. South America Optogenetics Actuators And Sensors Share (%), by Country
  • Figure 42. Asia Pacific Optogenetics Actuators And Sensors Share (%), by Country
  • Figure 43. Europe Optogenetics Actuators And Sensors Share (%), by Country
  • Figure 44. MEA Optogenetics Actuators And Sensors Share (%), by Country
  • Figure 45. North America Optogenetics Actuators And Sensors Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Addgene (United States)
  • Bruker (United States)
  • Circuit Therapeutics (United States)
  • Danaher (United States)
  • Elliot Scientific (United States)
  • Gensight Biologics (France)
  • Merck KGaA (Germany)
  • Prizmatix (Israel)
  • The Jackson Laboratory (United States)
  • Thorlabs (United States)
Additional players considered in the study are as follows:
Coherent , Noldus Information Technology , Scientifica , Shanghai Laser & Optics Century
Select User Access Type

Key Highlights of Report


Jul 2022 170 Pages 73 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Optogenetics Actuators And Sensors Market are Addgene (United States), Bruker (United States), Circuit Therapeutics (United States), Danaher (United States), Elliot Scientific (United States), Gensight Biologics (France), Merck KGaA (Germany), Prizmatix (Israel), The Jackson Laboratory (United States) and Thorlabs (United States) etc.
Neuroscience segment in Global market to hold robust market share owing to "Rise in incidence of neurological and mental disorders such as Parkinson’s disease, depression, and schizophrenia is driving the neurological disorders".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Optogenetics Actuators And Sensors market throughout the forecasted period.

Know More About Global Optogenetics Actuators And Sensors Market Report?